Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 17 04:00PM ET
2.36
Dollar change
+0.09
Percentage change
3.97
%
Index- P/E- EPS (ttm)-0.14 Insider Own12.23% Shs Outstand10.54M Perf Week12.38%
Market Cap24.87M Forward P/E59.00 EPS next Y0.04 Insider Trans6.18% Shs Float9.25M Perf Month18.59%
Income-1.44M PEG- EPS next Q-0.02 Inst Own40.44% Short Float0.03% Perf Quarter-32.76%
Sales14.06M P/S1.77 EPS this Y76.67% Inst Trans1.04% Short Ratio0.14 Perf Half Y12.92%
Book/sh0.78 P/B3.04 EPS next Y214.29% ROA-12.87% Short Interest0.00M Perf Year61.64%
Cash/sh0.34 P/C6.85 EPS next 5Y- ROE-16.84% 52W Range1.13 - 4.04 Perf YTD-31.79%
Dividend Est.- P/FCF- EPS past 5Y21.13% ROI-15.16% 52W High-41.63% Beta1.22
Dividend TTM- Quick Ratio2.77 Sales past 5Y24.85% Gross Margin58.86% 52W Low108.85% ATR (14)0.15
Dividend Ex-Date- Current Ratio4.21 EPS Y/Y TTM74.95% Oper. Margin-10.57% RSI (14)59.40 Volatility7.79% 6.15%
Employees31 Debt/Eq0.21 Sales Y/Y TTM21.78% Profit Margin-10.23% Recom1.00 Target Price4.75
Option/ShortNo / Yes LT Debt/Eq0.16 EPS Q/Q45.79% Payout- Rel Volume3.41 Prev Close2.27
Sales Surprise-13.47% EPS Surprise-140.00% Sales Q/Q-4.73% EarningsMar 07 AMC Avg Volume17.65K Price2.36
SMA208.59% SMA506.33% SMA2001.71% Trades Volume60,171 Change3.97%
Date Action Analyst Rating Change Price Target Change
Jan-26-21Initiated B. Riley Securities Buy $12.50
May-09-24 04:15PM
May-02-24 07:30AM
Apr-29-24 09:00AM
Apr-23-24 07:30AM
Mar-08-24 01:01PM
04:15PM Loading…
Mar-07-24 04:15PM
Feb-29-24 04:30PM
Nov-11-23 12:41PM
Nov-08-23 04:15PM
Nov-01-23 07:30AM
Oct-25-23 07:30AM
Sep-19-23 04:30PM
Aug-09-23 04:15PM
Jul-26-23 07:30AM
May-24-23 07:30AM
04:15PM Loading…
May-10-23 04:15PM
May-08-23 07:30AM
Apr-26-23 07:30AM
Apr-04-23 07:30AM
Mar-08-23 04:15PM
Mar-01-23 04:30PM
Feb-22-23 04:30PM
Jan-11-23 07:30AM
Nov-02-22 04:15PM
Oct-19-22 07:30AM
Oct-12-22 07:30AM
Oct-11-22 07:30AM
Sep-28-22 07:30AM
Sep-08-22 04:00PM
Aug-13-22 08:22AM
04:15PM Loading…
Aug-10-22 04:15PM
Jul-27-22 07:30AM
Jul-06-22 07:30AM
May-17-22 07:30AM
May-04-22 04:15PM
Apr-27-22 07:30AM
Apr-26-22 07:30AM
Mar-21-22 07:30AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Feb-09-22 07:30AM
Jan-13-22 07:30AM
Jan-11-22 07:30AM
Nov-23-21 04:15PM
Nov-08-21 07:30AM
Nov-04-21 04:15PM
Oct-21-21 07:30AM
Oct-08-21 07:30AM
Oct-05-21 07:30AM
Sep-15-21 09:39AM
Sep-06-21 11:42AM
Sep-01-21 07:30AM
Aug-05-21 04:15PM
Jul-28-21 03:03PM
Jul-12-21 07:30AM
Jul-09-21 04:18PM
Jul-08-21 11:20AM
07:30AM
05:07AM
Jun-29-21 08:50AM
Jun-23-21 09:35AM
May-31-21 08:50AM
May-06-21 04:15PM
02:45PM
Apr-26-21 07:30AM
Apr-09-21 05:29AM
Apr-05-21 07:30AM
Mar-16-21 07:45AM
Mar-10-21 07:30AM
Mar-04-21 02:07AM
Mar-01-21 04:15PM
02:30PM
Feb-22-21 07:30AM
Feb-18-21 07:30AM
Jan-22-21 02:21AM
Jan-12-21 07:30AM
Jan-05-21 10:55AM
Jan-04-21 07:30AM
Nov-29-20 09:33AM
Nov-19-20 06:45AM
Nov-09-20 07:30AM
Nov-05-20 04:27PM
02:30PM
Oct-29-20 07:30AM
Oct-24-20 10:47AM
Oct-16-20 07:30AM
Oct-13-20 07:30AM
Oct-07-20 07:30AM
Oct-06-20 07:30AM
Aug-31-20 05:00PM
Aug-25-20 07:30AM
Aug-14-20 07:30AM
Aug-06-20 01:43PM
Aug-05-20 04:15PM
Jul-29-20 07:30AM
Jul-22-20 07:30AM
Jul-16-20 11:00AM
Jul-14-20 07:30AM
Jul-13-20 07:30AM
Jul-08-20 07:30AM
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Banks Robert R. Jr.President and CEOMay 16 '24Buy2.2450,000112,05070,000May 16 04:49 PM
Amron Arthur HDirectorMar 12 '24Buy2.457,00017,1307,000Mar 14 04:28 PM
Banks Robert R. Jr.President and CEODec 07 '23Buy2.2018,00039,64720,000Dec 11 04:17 PM
Banks Robert R. Jr.President and CEOAug 15 '23Buy1.691,9013,2072,000Aug 15 04:15 PM
Banks Robert R. Jr.President and CEOAug 14 '23Buy1.509914899Aug 15 04:15 PM
Last Close
May 17 04:00PM ET
3.75
Dollar change
+0.01
Percentage change
0.27
%
IndexRUT P/E- EPS (ttm)-0.49 Insider Own4.92% Shs Outstand47.94M Perf Week11.28%
Market Cap180.04M Forward P/E- EPS next Y-0.19 Insider Trans-7.34% Shs Float45.64M Perf Month16.10%
Income-23.32M PEG- EPS next Q- Inst Own82.02% Short Float0.65% Perf Quarter1.08%
Sales236.36M P/S0.76 EPS this Y-466.67% Inst Trans5.38% Short Ratio5.00 Perf Half Y-17.22%
Book/sh9.34 P/B0.40 EPS next Y-11.76% ROA-3.43% Short Interest0.30M Perf Year-2.85%
Cash/sh0.46 P/C8.18 EPS next 5Y- ROE-5.08% 52W Range2.94 - 5.75 Perf YTD-15.92%
Dividend Est.- P/FCF3.11 EPS past 5Y- ROI-4.68% 52W High-34.78% Beta1.62
Dividend TTM- Quick Ratio3.41 Sales past 5Y-19.24% Gross Margin-0.95% 52W Low27.55% ATR (14)0.16
Dividend Ex-DateMay 09, 2019 Current Ratio3.52 EPS Y/Y TTM-202.23% Oper. Margin-16.97% RSI (14)64.86 Volatility4.80% 4.46%
Employees733 Debt/Eq0.13 Sales Y/Y TTM-43.20% Profit Margin-9.87% Recom1.00 Target Price4.30
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q-241.49% Payout- Rel Volume1.13 Prev Close3.74
Sales Surprise-22.18% EPS Surprise- Sales Q/Q-62.87% EarningsMay 02 BMO Avg Volume59.31K Price3.75
SMA2013.57% SMA508.06% SMA200-9.35% Trades Volume67,163 Change0.27%
Date Action Analyst Rating Change Price Target Change
Sep-30-19Downgrade Barclays Overweight → Equal Weight $6.50 → $3.50
Sep-11-19Downgrade Johnson Rice Buy → Hold
Aug-05-19Reiterated Imperial Capital Outperform $18 → $10
Jun-07-19Downgrade Stephens Overweight → Equal-Weight $25 → $7
May-03-19Reiterated Imperial Capital Outperform $22 → $18
Mar-19-19Downgrade Credit Suisse Outperform → Neutral $33 → $17
Mar-18-19Reiterated Imperial Capital Outperform $30 → $24
Mar-18-19Downgrade Tudor Pickering Buy → Hold
Jan-09-19Reiterated Imperial Capital Outperform $40 → $30
Jan-04-19Upgrade Tudor Pickering Hold → Buy
May-06-24 09:52AM
May-03-24 12:21AM
May-02-24 12:56PM
10:12AM
07:00AM
04:15PM Loading…
Apr-22-24 04:15PM
Mar-04-24 09:17AM
Mar-01-24 11:31PM
09:32AM
07:00AM
Feb-12-24 04:15PM
Dec-06-23 08:00AM
Nov-11-23 11:29AM
Nov-09-23 11:08PM
09:53AM
07:00AM Loading…
07:00AM
Nov-01-23 08:00AM
Oct-19-23 08:00AM
Aug-11-23 11:52PM
08:00AM
Jul-20-23 04:15PM
Jul-07-23 10:21AM
Jun-16-23 03:23PM
Jun-15-23 08:00AM
Jun-07-23 07:13AM
May-27-23 08:57AM
May-04-23 08:17AM
Apr-27-23 04:01PM
Apr-21-23 06:35AM
Apr-19-23 08:30AM
10:46PM Loading…
Feb-27-23 10:46PM
Feb-26-23 07:27AM
Feb-24-23 06:52AM
Feb-23-23 04:01PM
Feb-06-23 04:15PM
Jan-28-23 08:49AM
Jan-24-23 04:15PM
Jan-19-23 05:07PM
Jan-17-23 04:15PM
Dec-06-22 04:15PM
Nov-01-22 04:15PM
Oct-31-22 10:25AM
Oct-27-22 04:01PM
Oct-17-22 04:15PM
Sep-26-22 04:15PM
Aug-24-22 04:15PM
Aug-21-22 09:15AM
Jul-28-22 11:00PM
04:01PM
Jul-14-22 04:36PM
Jun-14-22 04:15PM
Jun-07-22 07:00AM
May-24-22 06:33AM
May-10-22 03:00PM
May-09-22 04:15PM
Apr-26-22 04:15PM
Mar-31-22 08:30AM
Mar-29-22 08:00AM
Mar-14-22 08:30AM
07:33AM
Mar-04-22 02:00PM
08:30AM
06:00AM
Feb-25-22 04:15PM
Dec-01-21 08:00AM
Nov-19-21 10:53AM
07:07AM
05:07AM
Nov-18-21 04:15PM
Nov-16-21 08:00AM
Nov-05-21 06:00AM
Nov-03-21 08:00AM
Oct-26-21 09:11AM
Oct-14-21 08:00AM
Oct-01-21 08:00AM
Sep-28-21 02:25PM
Jul-30-21 11:31AM
06:00AM
Jul-29-21 04:15PM
Jul-23-21 06:00AM
Jun-29-21 08:37AM
Jun-08-21 07:00AM
Apr-29-21 08:31PM
04:01PM
Apr-23-21 04:32PM
Mar-30-21 08:13AM
Mar-24-21 05:00AM
Mar-17-21 04:01PM
Feb-27-21 02:00AM
Feb-25-21 04:01PM
03:15PM
Feb-19-21 05:05PM
Feb-17-21 06:00AM
Dec-29-20 07:07AM
Dec-08-20 07:00AM
Dec-07-20 03:28PM
Oct-30-20 01:46PM
Oct-29-20 04:01PM
03:45PM
Oct-23-20 04:39PM
Mammoth Energy Services, Inc. engages in the exploration and development of North American onshore unconventional oil and natural gas reserves. It operates through the following segments: Infrastructure, Pressure Pumping, Natural Sand Proppant, Drilling, and Other. The Infrastructure segment offers construction, upgrade, maintenance and, repair services to the electrical infrastructure industry. The Pressure Pumping segment provides pressure pumping services, also known as hydraulic fracturing, to exploration and production companies. The Natural Sand Proppant segment refers to mining, processing, and selling sand. The Drilling segment includes contract land, directional drilling, and rig moving services. The company was founded on June 3, 2016 and is headquartered in Oklahoma City, OK.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Amron Arthur HDirectorMar 12 '24Buy3.723,00011,15713,279Mar 14 04:11 PM
Straehla ArtyChief Executive OfficerDec 19 '23Sale4.3540,000174,1601,012,107Dec 19 06:37 PM
Straehla ArtyChief Executive OfficerDec 18 '23Sale4.3830,000131,2801,052,107Dec 19 06:37 PM
Straehla ArtyChief Executive OfficerDec 15 '23Sale4.3640,000174,4401,082,107Dec 15 05:21 PM
Straehla ArtyChief Executive OfficerDec 14 '23Sale4.4455,000244,1451,122,107Dec 15 05:21 PM
Straehla ArtyChief Executive OfficerDec 13 '23Sale4.3925,000109,6501,177,107Dec 15 05:21 PM